{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:38:09Z","timestamp":1785530289649,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Survivors of childhood cancer and hematopoietic cell transplant are at risk for developing chronic health conditions, including hypertension. Studies have identified hypertension as an influential risk factor for late kidney dysfunction and cardiovascular disease in childhood cancer survivors. The overall risk of hypertension depends on the specific cancer treatment, from chemotherapy to surgery to radiation. In this report, we aim to review the main causes of hypertension in childhood cancer survivors, with a focus on newer therapies, as well as the current recommendations for screening and management of hypertension in this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Novel targeted therapies and immunotherapies are being increasingly used in pediatric cancer treatment, with unclear impact on long-term health. Screening guidelines for hypertension in the survivor population have been issued by various childhood cancer cooperative groups based on best available evidence and expert opinion. Newer studies have focused on individual risk prediction, which may help improve the diagnosis and management of hypertension, particularly in higher-risk individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Despite the importance of hypertension as one of the few modifiable risk factors for cardiovascular and renal health, studies have yet to define optimal blood pressure targets, screening parameters, or management strategies in childhood cancer survivors. Additionally, further studies are needed to demonstrate improvement in outcomes following interventions for hypertension specifically in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11906-025-01330-x","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:22:53Z","timestamp":1741933373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertension in Childhood Cancer Survivors: Causes, Screening, and Management"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3304-7772","authenticated-orcid":false,"given":"Natalie L.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-1530","authenticated-orcid":false,"given":"Coral D.","family":"Hanevold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"crossref","unstructured":"Chow EJ, Ness KK, Armstrong GT, Bhakta N, Yeh JM, Bhatia S, Landier W, Constine LS, Hudson MM, Nathan PC.\u00a0Current and coming challenges in the management of the survivorship population.\u00a0Semin Oncol.\u00a02020;47(1):23\u201339.","DOI":"10.1053\/j.seminoncol.2020.02.007"},{"issue":"12","key":"1330_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","volume":"32","author":"GT Armstrong","year":"2014","unstructured":"Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014;32(12):1218.","journal-title":"J Clin Oncol"},{"issue":"10112","key":"1330_CR3","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","volume":"390","author":"N Bhakta","year":"2017","unstructured":"Bhakta N, Liu Q, Ness KK, Baassiri M, Eissa H, Yeo F, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). The Lancet. 2017;390(10112):2569\u201382.","journal-title":"The Lancet"},{"issue":"18","key":"1330_CR4","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra1613984","volume":"376","author":"MH Rosner","year":"2017","unstructured":"Rosner MH, Perazella MA. Acute kidney injury in patients with cancer. N Engl J Med. 2017;376(18):1770\u201381.","journal-title":"N Engl J Med"},{"key":"1330_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpeds.2018.12.023","volume":"208","author":"PG Park","year":"2019","unstructured":"Park PG, Hong CR, Kang E, Park M, Lee H, Kang HJ, et al. Acute kidney injury in pediatric cancer patients. J Pediatr. 2019;208:243-50.e3.","journal-title":"J Pediatr"},{"issue":"15","key":"1330_CR6","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572\u201382.","journal-title":"N Engl J Med"},{"issue":"12","key":"1330_CR7","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","volume":"19","author":"TM Gibson","year":"2018","unstructured":"Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970\u201399: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2018;19(12):1590\u2013601.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1330_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00134-007-0579-1","volume":"33","author":"M Darmon","year":"2007","unstructured":"Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay \u00c9. Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med. 2007;33(5):765\u201372.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1330_CR9","first-page":"475","volume":"23","author":"MH Rosner","year":"2017","unstructured":"Rosner MH, Capasso G, Perazella MA. Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Curr Opin Crit Care. 2017;23(6):475\u201383.","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"1330_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/pbc.24829","volume":"61","author":"DR Dengel","year":"2014","unstructured":"Dengel DR, Kelly AS, Zhang L, Hodges JS, Baker KS, Steinberger J. Signs of early sub-clinical atherosclerosis in childhood cancer survivors. Pediatr Blood Cancer. 2014;61(3):532\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1330_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djz108","volume":"112","author":"Y Chen","year":"2020","unstructured":"Chen Y, Chow EJ, Oeffinger KC, Border WL, Leisenring WM, Meacham LR, et al. Traditional cardiovascular risk factors and individual prediction of cardiovascular events in childhood cancer survivors. JNCI: J Natl Cancer Inst. 2020;112(3):256\u201365.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"13","key":"1330_CR12","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","volume":"139","author":"SD De Ferranti","year":"2019","unstructured":"De Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association. Circulation. 2019;139(13):e603\u201334.","journal-title":"Circulation"},{"issue":"1","key":"1330_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ndt\/gfp485","volume":"25","author":"M Ando","year":"2010","unstructured":"Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant. 2010;25(1):278\u201382.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1330_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1200\/JCO.2013.52.6582","volume":"32","author":"EJ Chow","year":"2014","unstructured":"Chow EJ, Baker KS, Lee SJ, Flowers ME, Cushing-Haugen KL, Inamoto Y, et al. Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation. J Clin Oncol. 2014;32(3):191.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1330_CR15","first-page":"238","volume":"1","author":"JB Cohen","year":"2019","unstructured":"Cohen JB, Geara AS, Hogan JJ, Townsend RR. Hypertension in cancer patients and survivors: epidemiology, diagnosis, and management. Cardio Oncol. 2019;1(2):238\u201351.","journal-title":"Cardio Oncol"},{"issue":"29","key":"1330_CR16","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31(29):3673.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1330_CR17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1055-9965.EPI-17-0510","volume":"26","author":"TM Gibson","year":"2017","unstructured":"Gibson TM, Li Z, Green DM, Armstrong GT, Mulrooney DA, Srivastava D, et al. Blood pressure status in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol Biomark Prev. 2017;26(12):1705\u201313.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"1330_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","volume":"16","author":"PA Hoffmeister","year":"2010","unstructured":"Hoffmeister PA, Hingorani SR, Storer BE, Baker KS, Sanders JE. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16(4):515\u201324.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"1330_CR19","doi-asserted-by":"publisher","first-page":"e2022056918","DOI":"10.1542\/peds.2022-056918","volume":"150","author":"KL Foster","year":"2022","unstructured":"Foster KL, Salehabadi SM, Green DM, Xing M, Ness KK, Krull KR, et al. Clinical assessment of late health outcomes in survivors of Wilms tumor. Pediatrics. 2022;150(5):e2022056918.","journal-title":"Pediatrics"},{"issue":"9","key":"1330_CR20","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/pbc.24545","volume":"60","author":"DA Cozzi","year":"2013","unstructured":"Cozzi DA, Ceccanti S, Frediani S, Mele E, Cozzi F. Renal function adaptation up to the fifth decade after treatment of children with unilateral renal tumor: A cross-sectional and longitudinal study. Pediatr Blood Cancer. 2013;60(9):1534\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1330_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2215\/CJN.09980912","volume":"8","author":"IA Dekkers","year":"2013","unstructured":"Dekkers IA, Blijdorp K, Cransberg K, Pluijm SM, Pieters R, Neggers SJ, et al. Long-term nephrotoxicity in adult survivors of childhood cancer. Clin J Am Soc Nephrol. 2013;8(6):922\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"1330_CR22","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2215\/CJN.09620911","volume":"7","author":"SL Knijnenburg","year":"2012","unstructured":"Knijnenburg SL, Jaspers MW, van der Pal HJ, Schouten-van Meeteren AY, Bouts AH, Lieverst JA, et al. Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clin J Am Soc Nephrol. 2012;7(9):1416\u201327.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"1330_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjc.6600608","volume":"87","author":"S Bailey","year":"2002","unstructured":"Bailey S, Roberts A, Brock C, Price L, Craft A, Kilkarni R, et al. Nephrotoxicity in survivors of Wilms\u2019 tumours in the North of England. Br J Cancer. 2002;87(10):1092.","journal-title":"Br J Cancer"},{"issue":"1","key":"1330_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0022-3476(86)80781-8","volume":"108","author":"TR Welch","year":"1986","unstructured":"Welch TR, McAdams AJ. Focal glomerulosclerosis as a late sequela of Wilms tumor. J Pediatr. 1986;108(1):105\u20139.","journal-title":"J Pediatr"},{"key":"1330_CR25","first-page":"CD008944","volume":"3","author":"EC Kooijmans","year":"2019","unstructured":"Kooijmans EC, B\u00f6kenkamp A, Tjahjadi NS, Tettero JM, van Dulmen-den Broeder E, van der Pal HJ, et al. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev. 2019;3:CD008944.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1330_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/pbc.21695","volume":"51","author":"DP Jones","year":"2008","unstructured":"Jones DP, Spunt SL, Green D, Springate JE. Renal late effects in patients treated for cancer in childhood: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2008;51(6):724\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"1330_CR27","unstructured":"Children\u2019s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. 2023."},{"issue":"7","key":"1330_CR28","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1681\/ASN.2006020118","volume":"17","author":"S Hingorani","year":"2006","unstructured":"Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006;17(7):1995\u20132005.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1330_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0959-8049(95)00618-4","volume":"32","author":"S De Graaf","year":"1996","unstructured":"De Graaf S, Van Gent H, Reitsma-Bierens WCC, Van Luyk W, Dolsma W, Postma A. Renal function after unilateral nephrectomy for Wilms\u2019 tumour: the influence of radiation therapy. Eur J Cancer. 1996;32(3):465\u20139.","journal-title":"Eur J Cancer"},{"key":"1330_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-019-0658-x","volume":"20","author":"TD Ryan","year":"2019","unstructured":"Ryan TD, Nagarajan R, Godown J. Pediatric cardio-oncology: development of cancer treatment-related cardiotoxicity and the therapeutic approach to affected patients. Curr Treat Options Oncol. 2019;20:1\u201316.","journal-title":"Curr Treat Options Oncol"},{"issue":"10","key":"1330_CR31","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.02780312","volume":"7","author":"MA Perazella","year":"2012","unstructured":"Perazella MA. Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol. 2012;7(10):1713\u201321.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"34","key":"1330_CR32","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1097\/MD.0000000000001413","volume":"94","author":"CA Jim\u00e9nez-Triana","year":"2015","unstructured":"Jim\u00e9nez-Triana CA, Castel\u00e1n-Mart\u00ednez OD, Rivas-Ruiz R, Jim\u00e9nez-M\u00e9ndez R, Medina A, Clark P, et al. Cisplatin nephrotoxicity and longitudinal growth in children with solid tumors: a retrospective cohort study. Medicine. 2015;94(34):e1413.","journal-title":"Medicine."},{"issue":"2","key":"1330_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000168288","volume":"11","author":"MG Bianchetti","year":"1991","unstructured":"Bianchetti MG, Kanaka C, Ridolfi-L\u00fcthy A, Hirt A, Wagner HP, Oetliker OH. Persisting renotubular sequelae after cisplatin in children and adolescents. Am J Nephrol. 1991;11(2):127\u201330.","journal-title":"Am J Nephrol"},{"issue":"1","key":"1330_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bjc.1989.233","volume":"60","author":"D Sleijfer","year":"1989","unstructured":"Sleijfer D, Smit E, Meijer S, Mulder N, Postmus P. Acute and cumulative effects of carboplatin on renal function. Br J Cancer. 1989;60(1):116.","journal-title":"Br J Cancer"},{"issue":"2","key":"1330_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/pbc.20812","volume":"48","author":"W St\u00f6hr","year":"2007","unstructured":"St\u00f6hr W, Paulides M, Bielack S, J\u00fcrgens H, Koscielniak E, Rossi R, et al. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatr Blood Cancer. 2007;48(2):140\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1330_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.ejca.2010.01.002","volume":"46","author":"M Cardous-Ubbink","year":"2010","unstructured":"Cardous-Ubbink M, Geenen M, Schade K, Heinen R, Caron H, Kremer L, et al. Hypertension in long-term survivors of childhood cancer: a nested case-control study. Eur J Cancer. 2010;46(4):782\u201390.","journal-title":"Eur J Cancer"},{"issue":"10","key":"1330_CR37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill S, Stevens M. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer. 2000;82(10):1636.","journal-title":"Br J Cancer"},{"issue":"5","key":"1330_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ki.2015.30","volume":"87","author":"MA Perazella","year":"2015","unstructured":"Perazella MA, Izzedine H. New drug toxicities in the onco-nephrology world. Kidney Int. 2015;87(5):909\u201317.","journal-title":"Kidney Int"},{"issue":"6","key":"1330_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nrneph.2015.15","volume":"11","author":"C Porta","year":"2015","unstructured":"Porta C, Cosmai L, Gallieni M, Pedrazzoli P, Malberti F. Renal effects of targeted anticancer therapies. Nat Rev Nephrol. 2015;11(6):354.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"1330_CR40","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s00467-020-04842-7","volume":"36","author":"NL Wu","year":"2021","unstructured":"Wu NL, Hingorani S. Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients. Pediatr Nephrol. 2021;36(9):2675\u201386.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"1330_CR41","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/HYP.0000000000000224","volume":"80","author":"JB Cohen","year":"2023","unstructured":"Cohen JB, Brown NJ, Brown S-A, Dent S, Van Dorst DC, Herrmann SM, et al. Cancer therapy\u2013related hypertension: a scientific statement from the American Heart Association. Hypertension. 2023;80(3):e46\u201357.","journal-title":"Hypertension"},{"issue":"10","key":"1330_CR42","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jacc.2015.07.025","volume":"66","author":"W Li","year":"2015","unstructured":"Li W, Croce K, Steensma DP, McDermott DF, Ben-Yehuda O, Moslehi J. Vascular and metabolic implications of novel targeted cancer therapies: focus on kinase inhibitors. J Am Coll Cardiol. 2015;66(10):1160\u201378.","journal-title":"J Am Coll Cardiol"},{"key":"1330_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ctrv.2016.12.002","volume":"53","author":"H Abdel-Qadir","year":"2017","unstructured":"Abdel-Qadir H, Ethier J-L, Lee DS, Thavendiranathan P, Amir E. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis. Cancer Treat Rev. 2017;53:120\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1330_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/2047487318755193","volume":"25","author":"M Totzeck","year":"2018","unstructured":"Totzeck M, Mincu R-I, Mrotzek S, Schadendorf D, Rassaf T. Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: a meta-analysis of approximately 29,000 cancer patients. Eur J Prev Cardiol. 2018;25(5):482\u201394.","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"1330_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ajh.2010.25","volume":"23","author":"V Ranpura","year":"2010","unstructured":"Ranpura V, Pulipati B, Chu D, Zhu X, Wu S. Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis. Am J Hypertens. 2010;23(5):460\u20138.","journal-title":"Am J Hypertens"},{"issue":"1","key":"1330_CR46","first-page":"1","volume":"4","author":"C Glen","year":"2022","unstructured":"Glen C, Tan YY, Waterston A, Evans TRJ, Jones RJ, Petrie MC, et al. Mechanistic and clinical overview cardiovascular toxicity of BRAF and MEK inhibitors: JACC: CardioOncology state-of-the-art review. Cardio Oncology. 2022;4(1):1\u201318.","journal-title":"Cardio Oncology"},{"key":"1330_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.blre.2019.03.003","volume":"35","author":"E Gavriilaki","year":"2019","unstructured":"Gavriilaki E, Gkaliagkousi E, Grigoriadis S, Anyfanti P, Douma S, Anagnostopoulos A. Hypertension in hematologic malignancies and hematopoietic cell transplantation: an emerging issue with the introduction of novel treatments. Blood Rev. 2019;35:51\u20138.","journal-title":"Blood Rev"},{"issue":"5","key":"1330_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.ackd.2021.09.011","volume":"28","author":"P Gudsoorkar","year":"2021","unstructured":"Gudsoorkar P, Ruf R, Adnani H, Safdar K, Sparks MA. Onco-hypertension: an emerging specialty. Adv Chron Kidney Dis. 2021;28(5):477-89.e1.","journal-title":"Adv Chron Kidney Dis"},{"key":"1330_CR49","doi-asserted-by":"crossref","unstructured":"Waxman AJ, Clasen S, Hwang W-T, Garfall A, Vogl DT, Carver J, et al. Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis. JAMA Oncol. 2018;4(3):e174519-e.","DOI":"10.1001\/jamaoncol.2017.4519"},{"issue":"25","key":"1330_CR50","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.jacc.2019.10.049","volume":"74","author":"S Ganatra","year":"2019","unstructured":"Ganatra S, Carver JR, Hayek SS, Ky B, Leja MJ, Lenihan DJ, et al. Chimeric antigen receptor T-cell therapy for cancer and heart: JACC council perspectives. J Am Coll Cardiol. 2019;74(25):3153\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1330_CR51","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/petr.12483","volume":"19","author":"MS Didsbury","year":"2015","unstructured":"Didsbury MS, Mackie FE, Kennedy SE. A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant. 2015;19(5):460\u201370.","journal-title":"Pediatr Transplant"},{"issue":"23","key":"1330_CR52","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMra1404711","volume":"374","author":"S Hingorani","year":"2016","unstructured":"Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med. 2016;374(23):2256\u201367.","journal-title":"N Engl J Med"},{"issue":"2","key":"1330_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16(2):157\u201368.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1330_CR54","doi-asserted-by":"crossref","unstructured":"Robinson CH, Jeyakumar N, Luo B, Askenazi D, Deep A, Garg AX, Goldstein S, Greenberg JH, Mammen C, Nash DM, Parekh RS. Long-term kidney outcomes after pediatric acute kidney injury. J Am Soc Nephrol. 2024. p. 10-1681.","DOI":"10.1681\/ASN.0000000000000445"},{"key":"1330_CR55","unstructured":"Dutch Childhood Oncology Group (DCOG)\/Stichting Kinderoncologie Nederland (SKION). Follow-up after childhood cancer, more than 5 years after diagnosis\/Richtlijn follow-up na kinderkanker meer dan 5 jaar na diagnose. 2023.\u00a0https:\/\/prinsesmaxima.iprova.nl\/Portal\/#\/QC\/48-65-CG. Accessed 01-06-2024."},{"key":"1330_CR56","unstructured":"Skinner R, Wallace WHB, Levitt GA, editors. Therapy based long term follow up. 2nd ed. Leicester, United Kingdom, United Kingdom children's cancer study group: late effects group. 2005."},{"issue":"4","key":"1330_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/pbc.24445","volume":"60","author":"LC Kremer","year":"2013","unstructured":"Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60(4):543\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1330_CR58","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1470-2045(23)00012-8","volume":"24","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt MJ, Leerink JM, Mulder RL, Mavinkurve-Groothuis A, Kok W, Nohria A, et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2023;24(3):e108\u201320.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1330_CR59","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","volume":"16","author":"SH Armenian","year":"2015","unstructured":"Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16(3):e123\u201336.","journal-title":"Lancet Oncol"},{"key":"1330_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2021.06.021","volume":"156","author":"E van Dalen","year":"2021","unstructured":"van Dalen E, Mulder R, Suh E, Ehrhardt M, Aune G, Bardi E, et al. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eur J Cancer (Oxford, England: 1990). 2021;156:127\u201337.","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"3","key":"1330_CR61","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1542\/peds.2008-3688","volume":"123","author":"American Academy of Pediatrics Section on Hematology\/Oncology Children's Oncology Group","year":"2009","unstructured":"American Academy of Pediatrics Section on Hematology\/Oncology Children\u2019s Oncology Group. Long-term follow-up care for pediatric cancer survivors. Pediatrics. 2009;123(3):906\u201315.","journal-title":"Pediatrics."},{"issue":"2","key":"1330_CR62","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.juro.2011.03.110","volume":"186","author":"J Lange","year":"2011","unstructured":"Lange J, Peterson SM, Takashima JR, Grigoriev Y, Ritchey ML, Shamberger RC, et al. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol. 2011;186(2):378\u201386.","journal-title":"J Urol"},{"key":"1330_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11606-009-0995-8","volume":"24","author":"SH Armenian","year":"2009","unstructured":"Armenian SH, Bhatia S. Chronic health conditions in childhood cancer survivors: is it all treatment-related\u2014or do genetics play a role? J Gen Intern Med. 2009;24:395\u2013400.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"1330_CR64","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","volume":"33","author":"EJ Chow","year":"2015","unstructured":"Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, et al. Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol. 2015;33(5):394\u2013402.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1330_CR65","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1200\/JCO.22.01926","volume":"41","author":"NL Wu","year":"2023","unstructured":"Wu NL, Chen Y, Dieffenbach BV, Ehrhardt MJ, Hingorani S, Howell RM, et al. Development and validation of a prediction model for kidney failure in long-term survivors of childhood cancer. J Clin Oncol. 2023;41(12):2258\u201368.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1330_CR66","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/jamacardio.2018.0005","volume":"3","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM. The 2017 American College of Cardiology\/American Heart Association clinical practice guideline for high blood pressure in adults. JAMA cardiology. 2018;3(4):352\u20133.","journal-title":"JAMA cardiology"},{"issue":"3","key":"1330_CR67","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904.","journal-title":"Pediatrics."},{"key":"1330_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpeds.2020.12.005","volume":"230","author":"DI Chu","year":"2021","unstructured":"Chu DI, Ehlayel AM, Ginsberg JP, Meyers KE, Benton M, Thomas M, et al. Kidney outcomes and hypertension in survivors of Wilms tumor: a prospective cohort study. J Pediatr. 2021;230:215-20.e1.","journal-title":"J Pediatr"},{"issue":"1","key":"1330_CR69","doi-asserted-by":"publisher","first-page":"e30034","DOI":"10.1002\/pbc.30034","volume":"70","author":"K Javalkar","year":"2023","unstructured":"Javalkar K, Huang Y, Lyon SM, Palfrey H, Hartz J, Chen MH, et al. Clinical response to lifestyle counseling for dyslipidemia and elevated blood pressure in childhood cancer survivors. Pediatr Blood Cancer. 2023;70(1):e30034.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1330_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(23)00637-X","volume":"25","author":"SH Armenian","year":"2024","unstructured":"Armenian SH, Hudson MM, Lindenfeld L, Chen S, Chow EJ, Colan S, et al. Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial. Lancet Oncol. 2024;25(2):235\u201345.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1330_CR71","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","volume":"22","author":"JH Silber","year":"2004","unstructured":"Silber JH, Cnaan A, Clark BJ, Paridon SM, Chin AJ, Rychik J, et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol. 2004;22(5):820\u20138.","journal-title":"J Clin Oncol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-025-01330-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:02:42Z","timestamp":1770476562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-025-01330-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1007\/s11906-025-01330-x","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"28 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Wu declares no conflict of interest. Dr. Hanevold serves as a Section Editor for this journal but has no other conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors report no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Integrity of Research and Reporting"}}],"article-number":"13"}}